Financial Statements — NNDM
Balance Sheet
(in billions USD)| Metric | Q2
2026 | Q1
2026 | Q2
2024 | Q2
2023 |
|---|
| Cash & Equivalents | 0.35 | 0.36 | 0.23 | 0.45 |
| Accounts Receivable | 0.02 | 0.02 | -- | -- |
| Inventory | 0.03 | 0.03 | 0.02 | 0.02 |
| Total Current Assets | 0.50 | 0.51 | 0.80 | 0.99 |
| Property, Plant & Equipment | 0.02 | 0.02 | -- | -- |
| Goodwill | 0.00 | 0.00 | -- | -- |
| Intangible Assets | 0.02 | 0.02 | -- | -- |
| Total Non-current Assets* | 0.06 | 0.07 | 0.11 | 0.20 |
| Total Assets | 0.56 | 0.57 | -- | -- |
| Accounts Payable | 0.01 | 0.01 | -- | -- |
| Total Current Liabilities | 0.05 | 0.06 | 0.03 | 0.03 |
| Total Non-current Liabilities* | 0.03 | 0.03 | 0.01 | 0.02 |
| Total Liabilities | 0.08 | 0.09 | -- | -- |
| Total Stockholder Equity* | 0.48 | 0.49 | 0.87 | 1.15 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q2
2024 | Q2
2023 |
|---|
| Total Revenue | 28.96 | 29.73 | 28.35 | 29.70 |
| Cost of Revenue | 15.67 | 17.60 | -- | -- |
| Gross Profit | 13.29 | 12.13 | -- | -- |
| Research & Development | 5.79 | 8.20 | -- | -- |
| Selling, General & Admin | 12.91 | 15.21 | -- | -- |
| Total Operating Expenses | 0.19 | 0.49 | -- | -- |
| Operating Income | (20.57) | (64.49) | -- | -- |
| Pretax Income | (6.65) | (69.66) | (79.10) | 12.71 |
| Tax Provision | 0.15 | 0.00 | 0.13 | 0.15 |
| Net Income | (6.80) | (69.66) | -- | -- |
| Basic EPS | (0.03) | (0.34) | (0.35) | 0.05 |
| Diluted EPS | (0.03) | (0.34) | (0.35) | 0.05 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q2
2024 | Q2
2023 |
|---|
| Operating Cash Flow | (30.95) | (7.08) | (30.69) | (56.12) |
| Capital Expenditures | 0.05 | 0.17 | -- | -- |
| Free Cash Flow* | (31.00) | (7.25) | -- | -- |
| Investing Cash Flow | -- | 157.48 | 26.22 | (149.80) |
| Financing Cash Flow | -- | (0.04) | (72.63) | (23.71) |
* Derived from reported values
